Abstracts tagged "decision analysis and self-management"

Abstract Number: 1371 • 2019 ACR/ARP Annual Meeting
Create an Algorithm of Outcome Forecasting and Decision Making for RA Treatment: Data Mining and Machine Learning via the Smart System of Disease Management (SSDM)
Rong Mu¹, Chun Li ², Jing Yang ³, Xiaohan Wang ⁴, Bin Wu ⁵, Fengxiao Zhang ⁶, Yong Wang ⁷, Li Qin ⁸, Cundong Mi ⁹, Huifang Guo ¹⁰, Wei Wei ¹¹, Wei Liu ¹², Qingchun Huang ¹³, Jing Lu ¹⁴, Yang Liu ¹⁵, Huiling Li ¹⁶, Bing Wu ¹⁷, Hui Xiao ¹⁸, Yuhua Jia ¹⁹ and Fei Xiao ²⁰, ¹People's Hospital, Beijing University Medical School, Beijing, China (People's Republic), ²People's Hospital, Beijing University Medical School, Beijing, Beijing, China (People's Republic), ³Central Hospital of MianYang, Mianyang, Sichuan, China (People's Republic), ⁴Anyang district hospital, Fuyang, Hainan, China (People's Republic), ⁵Chongqing Hospital of Traditional Chinese Medicine, Chongqing, Chongqing, China (People's Republic), ⁶Hebei General Hospital, Shijiazhuang, Hebei, China (People's Republic), ⁷The first Hospital Affiliated to AMU (Southernwest Hospital), Chongqing, China (People's Republic), ⁸The No.3 People’s Hospital of HuZhou City, Huzhou, Zhejiang, China (People's Republic), ⁹The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (People's Republic), ¹⁰The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (People's Republic), ¹¹Tianjin Medical University General Hospital, Tianjin, Tianjin, China (People's Republic), ¹²First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (People's Republic), ¹³The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China (People's Republic), ¹⁴First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China (People's Republic), ¹⁵Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, Nei Mongol, China (People's Republic), ¹⁶Hubei Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China (People's Republic), ¹⁷Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), ¹⁸Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), ¹⁹Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), ²⁰Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)
Background/Purpose: Daily health care deals with a wide spectrum of RA patients from statuses of remission (R) to disease activities at low (L), moderate (M)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].